Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients by Chia-Chi Wang, Tai-Chung Tseng, Pin-Chao Wang, Hans Hsienhong Lin, Jia-Horng Kao

Get full text

Different risk factors between reflux symptoms and mucosal injury in gastroesophageal reflux disease by Chung-Hsien Li, Tsung-Cheng Hsieh, Tsung-Hsien Hsiao, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Chia-Chi Wang

Get full text

Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients by Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao

Get full text

Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients. by Ching-Sheng Hsu, Chun-Jen Huang, Jia-Horng Kao, Hans Hsienhong Lin, You-Chen Chao, Yen-Chun Fan, Pei-Shan Tsai

Get full text

A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin by Ching-Sheng Hsu, Shih-Jer Hsu, Hans Hsienhong Lin, Tai-Chung Tseng, Chia-Chi Wang, Ding-Shinn Chen, Jia-Horng Kao

Get full text

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk by Chia-Chi Wang, Tai-Chung Tseng, Tsung-Cheng Hsieh, Ching-Sheng Hsu, Pin-Chao Wang, Hans Hsienhong Lin, Jia-Horng Kao

Get full text

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients by Cheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, Kuo-Chih Tseng, Chih-Lin Lin, Tung-Hung Su, Tai-Chung Tseng, Hans Hsienhong Lin, Chia-Chi Wang, Jia-Horng Kao

Get full text